More type 1 diabetes patients in England to get artificial pancreas

The NHS in England secures cost-effective deals with suppliers to provide artificial pancreas devices to thousands of children and eligible adults living with type 1 diabetes. The Hybrid Closed Loop (HCL) system will monitor glucose levels and adjust insulin dosage automatically, reducing the need for injections. With £14.1 million in funding, NHS England aims to offer this technology to as many patients as possible, improving medical care and quality of life. This significant milestone will benefit around 270,000 people with type 1 diabetes in England, with a phased rollout over five years. NICE recommends the devices for children, pregnant women, and adults with high glucose levels. Diabetes UK welcomes this development and looks forward to a fair and speedy rollout.